Lupin Limited — Rifampicin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Rifampicin · $18.4M export value · DGFT Verified
Lupin Limited is the #1 Indian exporter of Rifampicin with $18.4M in export value and 369 verified shipments. Lupin Limited holds a 1.4% market share in Rifampicin exports across 58 countries. The company exports 38 pharmaceutical products worth $271.4M across 19 therapeutic categories.
Lupin Limited — Rifampicin Export Profile: Buyers & Destinations
Where Does Lupin Limited Export Rifampicin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.2M | 48 | 14.8% |
| NETHERLANDS | $1.7M | 37 | 11.8% |
| NIGERIA | $1.5M | 53 | 10.6% |
| SOUTH AFRICA | $1.1M | 26 | 7.8% |
| BRAZIL | $970.4K | 20 | 6.7% |
| MYANMAR | $805.4K | 17 | 5.6% |
| INDONESIA | $700.0K | 17 | 4.8% |
| KENYA | $550.4K | 21 | 3.8% |
| MADAGASCAR | $400.0K | 8 | 2.8% |
| PHILIPPINES | $350.0K | 8 | 2.4% |
Lupin Limited exports Rifampicin to 59 countries. The largest destination is UNITED STATES accounting for 14.8% of Lupin Limited's Rifampicin shipments, followed by NETHERLANDS (11.8%) and NIGERIA (10.6%). These destinations reflect Lupin Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rifampicin from Lupin Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UPS SUPPLY CHAIN SOLUTIONS | UNITED STATES | $2.2M | 48 |
| NATIONAL TUBERCULOSIS AND LEPROSY | NIGERIA | $1.2M | 42 |
| I+SOLUTIONS | NETHERLANDS | $851.0K | 19 |
| SEKRETARIAT DITJEN PENCEGAHAN DAN P | INDONESIA | $650.0K | 15 |
| MOREIRA AND PINHEIRO TRADING, LDA | BRAZIL | $600.0K | 12 |
| UPD LEA GLEN, | SOUTH AFRICA | $562.2K | 14 |
| GDF TILBURG SRS D102TC | NETHERLANDS | $502.2K | 11 |
| UNOPS NO 12 O PYITHU LANE 7 MILE | MYANMAR | $450.0K | 9 |
| UPD LEA GLEN, PHARMA DYNAMICS C/O | SOUTH AFRICA | $424.7K | 9 |
| DEPARTMENT OF HEALTH | PHILIPPINES | $350.0K | 7 |
Lupin Limited supplies Rifampicin to 99 buyers globally. The largest buyer is UPS SUPPLY CHAIN SOLUTIONS (UNITED STATES), followed by NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) and I+SOLUTIONS (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rifampicin Export Value and How Much Does Lupin Limited Contribute?
India exported $121.8M worth of Rifampicin through 3,913 shipments from 175 suppliers to 162 countries, serving 780 buyers globally. Lupin Limited contributes $18.4M to this total, accounting for 1.4% of India's Rifampicin exports. Lupin Limited ships Rifampicin to 59 countries through 99 buyers.
What Is the Average Shipment Value for Lupin Limited's Rifampicin Exports?
Lupin Limited's average Rifampicin shipment value is $50.0K per consignment, based on 369 shipments totaling $18.4M. The largest destination is UNITED STATES (14.8% of Lupin Limited's Rifampicin exports).
How Does Lupin Limited Compare to Other Indian Rifampicin Exporters?
Lupin Limited ranks #1 among 175 Indian Rifampicin exporters with a 1.4% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($64.0M), MACLEODS PHARMACEUTICALS LIMITED ($18.5M), LUPIN LIMITED ($18.4M). Lupin Limited processed 369 shipments to 58 destination countries.
What Rifampicin Formulations Does Lupin Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 4 FDC 24X28T GDF Rifampicin, Isoniazid, | $934.1K | 19 |
| 4 FDC TABLET ALU ALU(RF-IH-ET-PY)BRA(RIFAMPICIN 150MG+ISONIAZID 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL HCL 275MG)-1BOXx15x6T | $600.0K | 12 |
| STOP TB CAT I & III PATIENT KIT-A (GDF)RIFAMPICIN 150MG+ ISONIAZIDE 75MG+ PYRAZINAMIDE 400MG+ ETHAMBUTOL 275MG) 6X28TABTBS | $450.0K | 9 |
| STOP TB CAT I & III PATIENT KIT-AGDF RIFAMPICIN 150MG+ISONIAZIDE 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL 275MG | $400.0K | 8 |
| RIFAMPICIN 150MG+ISONIAZIDE 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL 275MG)6X28TAB+RIFAMPICIN 150MG+IS(QTY 5494 BOX ) | $292.1K | 6 |
| STOP TB CAT I & III PATIENT KIT-A (GDF)Rifampicin 150mg+ Isoniazide 75mg+ Pyrazinamide 400mg+ Ethambutol*** | $250.0K | 5 |
| STOP TB CAT I+II KIT ARIFAMPICIN150MG+ISONIAZID75MG+PYRAZINAMIDE400MG+ETHAMBUTOL275MG6x28T+RIFA.150MG+ISO.75MG12x28T | $200.0K | 4 |
| STOP TB CAT I+II KIT ARIFAMPICIN150MG+ISONIAZID75MG+PYRAZINAMIDE400MG+ETHAMBUTOL275MG6x28T+ RIFA.150MG+ISO.75MG12x28T | $200.0K | 4 |
| RIFAMPIN CAPSULES 300MG (RIFAMPIN USP 300MG) - 1BTLx60 CAPS (RIFAMPICIN) | $200.0K | 4 |
| STOP TB CAT I & III PATIENT KIT-A (GDF)RIFAMPICIN 150MG+ ISONIAZIDE 75MG+ PYRAZINAMIDE 400MG+ ETHAMBUTOL 275MG) | $200.0K | 4 |
Lupin Limited exports 207 distinct Rifampicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 4 FDC 24X28T GDF Rifampicin, Isoniazid, with 19 shipments worth $934.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Rifampicin to Key Markets
What Lupin Limited must comply with to export Rifampicin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Lupin Limited Compare to Nearest Rifampicin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MACLEODS PHARMACEUTICALS LTD | $64.0M | 1,280 | 124 | $50.0K |
| 3 | MACLEODS PHARMACEUTICALS LIMITED | $18.5M | 387 | 87 | $47.7K |
| 1 | LUPIN LIMITED ★ | $18.4M | 369 | 58 | $50.0K |
| 4 | MANEESH PHARMACEUTICALS LIMITED | $10.3M | 207 | 41 | $50.0K |
| 5 | SVIZERA LABS PRIVATE LIMITED | $3.9M | 77 | 16 | $50.0K |
Lupin Limited ranks #1 among 175 Indian Rifampicin exporters. Average shipment value of $50.0K compared to the market average of $696.0K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and MACLEODS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Rifampicin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 947 | 24.2% |
| SAHAR AIR | 813 | 20.8% |
| DELHI AIR CARGO ACC (INDEL4) | 477 | 12.2% |
| DELHI AIR | 404 | 10.3% |
| NHAVA SHEVA SEA (INNSA1) | 295 | 7.5% |
| Bombay Air | 175 | 4.5% |
| JNPT/ NHAVA SHEVA SEA | 116 | 3.0% |
| JNPT | 99 | 2.5% |
What Other Advanced Antibiotics Products Does Lupin Limited Export?
Lupin Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Lupin Limited's Rifampicin Exports
Lupin's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, thereby escalating shipping costs for Indian exporters. (sgexports.odoo.com) Additionally, the 2025 United States–India diplomatic and trade crisis resulted in the U.S. imposing a 50% tariff on Indian exports, significantly affecting the competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org)
Conversely, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) poses compliance challenges for Indian exporters, including Lupin, necessitating adherence to stringent carbon reporting requirements. However, the EU's focus on reducing dependency on Chinese pharmaceutical imports presents an opportunity for Indian companies to capture a larger share of the European market.
Lupin Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Lupin's global operations. In February 2025, the U.S. FDA completed a Pre-Approval Inspection at Lupin's Somerset, New Jersey facility with zero observations, reflecting the company's commitment to compliance and quality. (lupin.com) However, the evolving regulatory landscape, including the EU's falsified medicines directive and the U.S. FDA's increasing scrutiny, necessitates continuous investment in quality assurance and regulatory compliance to ensure uninterrupted market access.
About Lupin Limited
Lupin Limited exports 38 products worth $271.4M. Beyond Rifampicin, top products include Isoniazid, Cephalexin, Simvastatin, Amlodipine, Pyrazinamide. View the complete Lupin Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rifampicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rifampicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lupin Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 369 individual customs records matching Lupin Limited exporting Rifampicin, covering 207 formulations to 59 countries via 99 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 162+ countries, 780+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rifampicin Export Data from Lupin Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lupin Limited's Rifampicin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lupin Limited
Full Company Profile →
38 products · $271.4M total trade · 19 categories
Rifampicin Stats
Company Overview
Top Products by Lupin Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lupin Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rifampicin. For current shipment-level data, contact TransData Nexus.